HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Experiences of photodynamic therapy in dermatology.

Abstract
From March 1988 to May 1994, 15 patients underwent the treatment protocol of superficial photodynamic therapy (PDT) in dermatological localized malignancies. Two tumours (one M. Queyrat of the penis, one basalioma) were treated primarily; the other 13 patients experienced relapses of underlying disease after treatment by surgery, radiotherapy or chemotherapy. Most of the patients (10/15) received doses of 2 mg Photosan III kg-1 body weight (BW), four received a lower dose of 1-1.5 mg kg-1 BW and one patient received 3 mg kg-1 BW. Only one remarkable side-effect (tachyarrhythmia) during Photosan III infusion occurred. All patients were treated by an argon dye laser system. The light dose was 200 J cm-2 (11 patients) and 150 J cm-2 (four patients). Complete response occurred in six lesions, including one M. Queyrat and five basaliomas. Two patients had significant partial response with distinct regression of tumour (one pretreated basalioma of the upper lip and one superficially spreading mesothelioma of the scrotum). Five patients (all basaliomas) demonstrated only local response and two patients gave no response (one basalioma, one melanoma metastasis). The results obtained from this small sample suggest the necessity of an optical dosimetric system. At present, PDT should be restricted for selected or pretreated cases.
AuthorsG Koderhold, R Jindra, H Koren, G Alth, G Schenk
JournalJournal of photochemistry and photobiology. B, Biology (J Photochem Photobiol B) Vol. 36 Issue 2 Pg. 221-3 (Nov 1996) ISSN: 1011-1344 [Print] Switzerland
PMID9002265 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Hematoporphyrins
  • Photosensitizing Agents
  • photosan III
Topics
  • Carcinoma, Basal Cell (drug therapy)
  • Dermatology (methods)
  • Eye Neoplasms (drug therapy)
  • Hematoporphyrins
  • Humans
  • Male
  • Mesothelioma (drug therapy)
  • Penile Neoplasms (drug therapy)
  • Photochemotherapy
  • Photosensitizing Agents (therapeutic use)
  • Testicular Neoplasms (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: